Malignant pleural mesothelioma: an epidemiological perspective

被引:217
|
作者
Robinson, Benjamin M. [1 ]
机构
[1] Baird Inst Appl Heart & Lung Surg Res, Sydney, NSW, Australia
关键词
Asbestos; epidemiology; incidence; malignant mesothelioma;
D O I
10.3978/j.issn.2225-319X.2012.11.04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper reviews the aetiology, distribution and projected future incidence of malignant mesothelioma. Asbestos exposure is the most thoroughly established risk factor. Debate continues regarding the relative importance of the different asbestos fibre types and the contribution of Simian virus 40 (SV40). Disease incidence varies markedly within and between countries. The highest annual rates of disease, approximately 30 case per million, are reported in Australia and Great Britain. The risk of disease increases with age and is higher in men. Time from asbestos exposure to disease diagnosis is on average greater than 40 years. Nonoccupational asbestos exposures contribute an increasing proportion of disease. With the exception of the United States, incidence continues to increase. In developed countries peak incidence is expected to occur before 2030.
引用
收藏
页码:491 / 496
页数:6
相关论文
共 50 条
  • [41] Malignant pleural mesothelioma: role of thoracoscopy
    Astoul, P
    Boutin, C
    BRONCHOLOGY AND BRONCHOESOPHAGOLOGY: STATE OF THE ART, 2001, 1217 : 159 - 169
  • [42] Advances in the biology of malignant pleural mesothelioma
    Zucali, P. A.
    Ceresoli, G. L.
    De Vincenzo, F.
    Simonelli, M.
    Lorenzi, E.
    Gianoncelli, L.
    Santoro, A.
    CANCER TREATMENT REVIEWS, 2011, 37 (07) : 543 - 558
  • [43] Subarachnoid-pleural fistula as a complication of malignant pleural mesothelioma
    Heyer, Christoph M.
    Theile, Anja
    Weisser, Heike
    Reichert, Joseph
    Horch, Christoph
    Mueller, Klaus-M.
    Bauer, Torsten T.
    RESPIROLOGY, 2006, 11 (04) : 502 - 505
  • [44] Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma
    Fujimoto, Nobukazu
    Gemba, Kenichi
    Asano, Michiko
    Fuchimoto, Yasuko
    Wada, Sae
    Ono, Katsuichiro
    Ozaki, Shinji
    Kishimoto, Takumi
    RESPIRATORY INVESTIGATION, 2013, 51 (02) : 92 - 97
  • [45] Malignant pleural mesothelioma: A retrospective analysis of clinicopathological and survival data
    Adel, Azza M.
    Hafeez, Zeinab M. Abdel
    El Sheikh, Eman T.
    El Sharawy, Iman A.
    Gobran, Nagy S.
    THORACIC CANCER, 2011, 2 (01) : 16 - 23
  • [46] Review of staging and diagnosis of malignant pleural mesothelioma
    Jordan, Sean
    Nitsche, Lindsay
    Yendamuri, Sai
    AME SURGICAL JOURNAL, 2022, 2
  • [47] Malignant Pleural Mesothelioma: Socioeconomic and Clinical Aspects
    Pandey, Swaroop Kumar
    Yadav, Neha
    Mishra, Anuja
    Sohal, Jagdip Singh
    Thakur, Komal
    Dwivedi-Agnihotri, Hemlata
    CURRENT CANCER THERAPY REVIEWS, 2024,
  • [48] Hotspots of malignant pleural mesothelioma in Western Europe
    Nuyts, Valerie
    Nawrot, Tim
    Nemery, Benoit
    Nackaerts, Kristiaan
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (05) : 516 - +
  • [49] Current chemotherapeutic treatment of malignant pleural mesothelioma
    Nowak, AK
    Byrne, MJ
    Millward, MJ
    Alvarez, JM
    Robinson, BWS
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (12) : 2441 - 2449
  • [50] Malignant Pleural Mesothelioma Updates for Respiratory Physicians
    Sidhu, Calvin
    Louw, Amber
    Lee, Y. C. Gary
    CLINICS IN CHEST MEDICINE, 2021, 42 (04) : 697 - 710